Ceridian HCM (NYSE:CDAY) had its target price lifted by analysts at Goldman Sachs Group from $62.00 to $72.00 in a research report issued to clients and investors on Monday, The Fly reports. Goldman Sachs Group’s price target points to a potential downside of 8.02% from the company’s previous close.

A number of other brokerages have also recently commented on CDAY. Mizuho raised their price objective on Ceridian HCM from $60.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. CIBC assumed coverage on Ceridian HCM in a research note on Thursday, March 5th. They issued an “outperformer” rating and a $84.00 price objective for the company. Wells Fargo & Co dropped their target price on Ceridian HCM from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. BMO Capital Markets raised their target price on Ceridian HCM from $74.00 to $75.00 and gave the company a “market perform” rating in a report on Thursday, May 7th. Finally, Credit Suisse Group raised their target price on Ceridian HCM from $47.00 to $49.00 and gave the company an “underperform” rating in a report on Thursday, May 7th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $66.17.

Shares of Ceridian HCM stock opened at $78.28 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.08 and a current ratio of 1.08. Ceridian HCM has a 52 week low of $38.40 and a 52 week high of $83.89. The stock has a 50 day moving average price of $71.96 and a two-hundred day moving average price of $65.19. The stock has a market capitalization of $11.59 billion, a PE ratio of 153.49 and a beta of 1.67.

Ceridian HCM (NYSE:CDAY) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.15 EPS for the quarter, beating the Zacks’ consensus estimate of $0.12 by $0.03. Ceridian HCM had a return on equity of 1.80% and a net margin of 9.03%. The firm had revenue of $222.70 million during the quarter, compared to analysts’ expectations of $218.42 million. During the same quarter last year, the firm posted $0.14 earnings per share. The company’s revenue for the quarter was up 9.3% compared to the same quarter last year. Research analysts forecast that Ceridian HCM will post 0.17 EPS for the current year.

In other Ceridian HCM news, CEO David D. Ossip sold 500,000 shares of the business’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $81.00, for a total value of $40,500,000.00. Following the sale, the chief executive officer now directly owns 1,059,873 shares in the company, valued at $85,849,713. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Arthur Gitajn sold 86,500 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $65.51, for a total value of $5,666,615.00. The disclosure for this sale can be found here. Insiders have sold 4,305,461 shares of company stock worth $285,602,275 over the last quarter. 17.60% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Ceridian HCM in the first quarter valued at $33,000. Advisors Preferred LLC bought a new stake in shares of Ceridian HCM in the first quarter valued at $70,000. Advisor Group Holdings Inc. bought a new stake in shares of Ceridian HCM in the first quarter valued at $163,000. Dupont Capital Management Corp raised its stake in shares of Ceridian HCM by 50.8% in the first quarter. Dupont Capital Management Corp now owns 3,711 shares of the company’s stock valued at $186,000 after buying an additional 1,250 shares during the period. Finally, Metropolitan Life Insurance Co NY grew its position in shares of Ceridian HCM by 35.4% in the first quarter. Metropolitan Life Insurance Co NY now owns 3,655 shares of the company’s stock valued at $187,000 after purchasing an additional 955 shares in the last quarter. Hedge funds and other institutional investors own 89.00% of the company’s stock.

About Ceridian HCM

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Featured Story: Price-Sales Ratio

The Fly

Analyst Recommendations for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.